Table I.
Characteristic | Aflibercept (n=40) | Ranibizumab (n=40) | P-value |
---|---|---|---|
Sex | |||
Male | 17 (42.5) | 19 (47.5) | >0.05 |
Female | 23 (57.5) | 21 (52.5) | |
Age (years) | 60.5±4.3 | 62.4±7.1 | 0.15 |
Course of disease (months) | 39.5±9.2 | 43.5±13.2 | 0.12 |
Values are expressed as n (%) or mean ± standard deviation.